Twist Bioscience Corporation
DE ˙ DB ˙ US90184D1000 ˙ Biotechnology
€ 127,30 ↑2.35 (1.88%)
2026-10-16
PREÇO DA AÇÃO
SecurityDE:0ME / Twist Bioscience Corporation
InstitutionUbs Asset Management Americas Inc
Latest Disclosed Ownership563,782 shares
Latest Disclosed Value $ 58,001,893
Ubs Asset Management Americas Inc reports 31.58% decrease in ownership of 0ME / Twist Bioscience Corporation

On August 13, 2026 - Ubs Asset Management Americas Inc filed a 13F-HR form disclosing ownership of 563,782 shares of Twist Bioscience Corporation (DE:0ME) valued at $48,090,605 USD as of June 30, 2026. The entity filed a previous 13F-HR on May 13, 2026 disclosing 823,976 shares of Twist Bioscience Corporation. This represents a change in shares of -31.58% during the quarter. The current value of the position is $71,769,449 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-08-13 2026-06-30 13F TWIST BIOSCIENCE COM 90184D100 563,782 -260,194 -31.58 58,002 48.13 0.0105
2026-05-13 2026-03-31 13F TWIST BIOSCIENCE COM 90184D100 823,976 -349,124 -29.76 39,155 5.23 0.0081
2026-02-13 2025-12-31 13F TWIST BIOSCIENCE COM 90184D100 1,173,100 49,403 4.40 37,211 17.68 0.0079
2025-11-14 2025-09-30 13F TWIST BIOSCIENCE COM 90184D100 1,123,697 -95,691 -7.85 31,621 -29.52 0.0069
2025-08-14 2025-06-30 13F TWIST BIOSCIENCE COM 90184D100 1,219,388 -1,222,874 -50.07 44,861 -53.21 0.0091
2025-05-19 2025-03-31 13F TWIST BIOSCIENCE COM 90184D100 2,442,262 1,588,587 186.09 95,883 141.70 0.0246
2025-02-14 2024-12-31 13F TWIST BIOSCIENCE COM 90184D100 853,675 -26,524 -3.01 39,670 -0.24 0.0093
2024-11-14 2024-09-30 13F TWIST BIOSCIENCE COM 90184D100 880,199 -81,038 -8.43 39,767 -16.05 0.0102
2024-08-14 2024-06-30 13F TWIST BIOSCIENCE COM 90184D100 961,237 869,362 946.24 47,370 1,402.82 0.0136
2024-05-15 2024-03-31 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 91,875 0 0.00 3,152 -6.91 0.0011
2024-02-14 2023-12-31 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 91,875 11,040 13.66 3,387 106.84 0.0013
2023-11-13 2023-09-30 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 80,835 32,287 66.51 1,638 123.63 0.0007
2023-08-11 2023-06-30 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 48,548 0 0.00 732 0.00 0.0004
2023-05-15 2023-03-31 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 48,548 -8,347 -14.67 732 -45.94 0.0004
2023-02-14 2022-12-31 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 56,895 2,601 4.79 1,355 -29.22 0.0007
2022-11-14 2022-09-30 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 54,294 2,121 4.07 1,913 4.94 0.0011
2022-08-12 2022-06-30 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 52,173 -2,704 -4.93 1,824 -32.71 0.0010
2022-05-16 2022-03-31 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 54,877 4,026 7.92 2,710 -31.16 0.0012
2022-02-14 2021-12-31 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 50,851 8,482 20.02 3,935 -13.17 0.0015
2021-11-15 2021-09-30 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 42,369 1,162 2.82 4,532 -17.45 0.0019
2021-08-16 2021-06-30 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 41,207 9,841 31.37 5,491 41.35 0.0023
2021-05-14 2021-03-31 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 31,366 -52,373 -62.54 3,885 -67.17 0.0017
2021-03-01 2020-12-31 13F/A-1 TWIST BIOSCIENCE EQUITY US CM 90184D100 83,739 -55,395 -39.81 11,831 11.93 0.0055
2021-02-17 2020-12-31 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 139,134 0 10,570 0.9969
2020-11-13 2020-09-30 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 139,134 -46,377 -25.00 10,570 25.79 0.0057
2020-08-14 2020-06-30 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 185,511 167,443 926.74 8,404 1,422.28 0.0051
2020-05-15 2020-03-31 13F TWIST BIOSCIENCE EQUITY US CM 90184D100 18,068 18,068 553 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.